Hofstädter F, Jakse G, Lederer B, Mikuz G
Pathol Res Pract. 1980;167(2-4):254-64. doi: 10.1016/S0344-0338(80)80055-0.
Forty-nine patients with transitional cell tumors of the urinary bladder were followed up clinically for a period of at least 36 months (average time 61.4 months). Initial tumors were examined by means of DNA-Feulgencytophotometry. Histologic grading was performed according to Bergkvist et al. (1965). Clinical behavior clearly demonstrates the validity of the grading schedule used and shows the significance of DNA-Feulgencytophotometry for the standardization of bladder tumors and for the comparability of diagnostic and therapeutic results. Determination of the individual prognosis of low-malignancy tumors and the differentiation of histologic borderline cases does not appear to be possible by means of DNA-Feulgencytophotometry.
49例膀胱移行细胞肿瘤患者接受了至少36个月（平均61.4个月）的临床随访。对初始肿瘤进行了DNA荧光光度法检测。组织学分级按照Bergkvist等人（1965年）的方法进行。临床行为清楚地证明了所使用的分级方案的有效性，并显示了DNA荧光光度法对于膀胱肿瘤标准化以及诊断和治疗结果可比性的重要性。通过DNA荧光光度法似乎无法确定低恶性肿瘤的个体预后以及组织学临界病例的鉴别诊断。
